Vascular Embolization Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global vascular embolization market was valued at $3,682.73 million in 2021, and is projected to reach $7,780.98 million by 2031, registering a CAGR of 7.7% from 2022 to 2031.

A minimally invasive process called embolization inhibits blood flow in certain places. The procedure is carried out while preserving regular blood flow in the surrounding areas to protect tissues while managing problematic bleeding. When a blood vessel becomes blocked, it is called an embolism, and when a blood vessel is purposefully blocked for medical reasons, it is called an embolization operation. A catheter-based technique called coil embolization enables exact blockage of aberrant blood flow in a blood artery. An artery, typically in the groin, is entered using a catheter with a metallic occluding coil (the femoral artery).

The aberrant blood vessel is then reached by the advancement. By moving forward with blood flow and penetrating deeper into the vascular bed to locations where a catheter or coil may not reach, liquid embolic agents have the capacity to fill the target vessel and cause vascular blockage. Detachable balloons have an advantage over other embolization techniques such as embolization through detachable balloons is reversible until the balloon is removed. Large arteries and fistulae can be instantly and precisely occluded .The growth of global vascular embolization market is majorly driven by an alarming increase in prevalence of vascular diseases. Increase in improvements in vascular disease treatment by embolization techniques and products also accelerates the growth of the vascular embolization market.

Moreover, increased success rate of embolization plugs in non-invasive procedures for vascular occlusion, its availability as a viable alternative to conventional procedure and other technological advancement in this is anticipated to drive the market even more. To site an example, the Amplatzer Plug 4 by St. Jude Medical, Inc. is easily available in the market. However, high cost of vascular embolization, complications associated with it, hinders the growth of the market. In addition, therapies like chemotherapy, and radiation therapy are preferred options in the treatment of cancer because people are generally aware of traditional cancer treatments, advanced treatment options are not widely used and oncologists are reluctant to switch from traditional treatment options. In addition, risk of lodging an embolic agent in the wrong place can deprive normal tissues of oxygen. These are the factors which will negatively impact the growth of the market.

The global vascular embolization market is segmented into product, application, and end user. By product, the market is categorized into embolic agents and embolization devices. Embolic agents and Embolic Devices are further sub categorized into liquid embolic agents and microspheres. And embolization devices are classified into coils, detachable balloons, embolic plugs, and support devices.

On the basis of application, the market is segregated into oncology, peripheral vascular diseases, urology and nephrology, neurology and others. On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers and others. By region market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).Major key players that operate in the global vascular embolization market are Abbott Laboratories., Balt Group, Boston Scientific Corporation, Cook Medical, Johnson and Johnson, Kaneka Corporation, Medtronic Plc, Merit Medical, Stryker Corporation, and Terumo Medical Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vascular embolization market analysis from 2021 to 2031 to identify the prevailing vascular embolization market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the vascular embolization market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global vascular embolization market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Embolic Agents
- Type
- Liquid Embolic Agents
- Microspheres
Embolization Devices
- Type
- Coils
- Detachable Balloons
- Embolic Plug
- Support Devices

By Application

Oncology
Peripheral Vascular Diseases
Urology and Nephrology
Neurology
Others

By End User

Hospitals and Clinics
Ambulatory Surgical Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest Of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- BOSTON SCIENTIFIC CORPORATION
- MERIT MEDICAL SYSTEMS
- TERUMO CORPORATION
- MEDTRONIC PLC
- ABBOTT LABORATORIES
- DEPUY SYNTHES (J&J MEDICAL DEVICES)
- COOK MEDICAL
- BALT
- KANEKA CORPORATION
- STRYKER CORPORATION

Product Code: A13246

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: VASCULAR EMBOLIZATION MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Embolic Agents
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Embolic Agents Vascular Embolization Market by Type
  - 4.2.4.1 Liquid Embolic Agents Market size and forecast, by region
  - 4.2.4.2 Microspheres Market size and forecast, by region
4.3 Embolization Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Embolization Devices Vascular Embolization Market by Type
  - 4.3.4.1 Coils Market size and forecast, by region
  - 4.3.4.2 Detachable Balloons Market size and forecast, by region
  - 4.3.4.3 Embolic Plug Market size and forecast, by region
  - 4.3.4.4 Support Devices Market size and forecast, by region

CHAPTER 5: VASCULAR EMBOLIZATION MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Oncology
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Peripheral Vascular Diseases
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Urology and Nephrology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Neurology
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country

CHAPTER 6: VASCULAR EMBOLIZATION MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: VASCULAR EMBOLIZATION MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
  - 7.2.2.1 North America Embolic Agents Vascular Embolization Market by Type
  - 7.2.2.2 North America Embolization Devices Vascular Embolization Market by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Product
  - 7.2.5.1.2 Market size and forecast, by Application
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Product
  - 7.2.5.2.2 Market size and forecast, by Application
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Product
  - 7.2.5.3.2 Market size and forecast, by Application
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
  - 7.3.2.1 Europe Embolic Agents Vascular Embolization Market by Type
  - 7.3.2.2 Europe Embolization Devices Vascular Embolization Market by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Product
  - 7.3.5.1.2 Market size and forecast, by Application
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Product
  - 7.3.5.2.2 Market size and forecast, by Application
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 UK
  - 7.3.5.3.1 Market size and forecast, by Product
  - 7.3.5.3.2 Market size and forecast, by Application
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Product
  - 7.3.5.4.2 Market size and forecast, by Application
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Product
  - 7.3.5.5.2 Market size and forecast, by Application
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Product
  - 7.3.5.6.2 Market size and forecast, by Application
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
  - 7.4.2.1 Asia-Pacific Embolic Agents Vascular Embolization Market by Type
  - 7.4.2.2 Asia-Pacific Embolization Devices Vascular Embolization Market by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 China
  - 7.4.5.1.1 Market size and forecast, by Product
  - 7.4.5.1.2 Market size and forecast, by Application
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 Japan
  - 7.4.5.2.1 Market size and forecast, by Product
  - 7.4.5.2.2 Market size and forecast, by Application
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 India
  - 7.4.5.3.1 Market size and forecast, by Product
  - 7.4.5.3.2 Market size and forecast, by Application
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 Australia
  - 7.4.5.4.1 Market size and forecast, by Product
  - 7.4.5.4.2 Market size and forecast, by Application
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Product
  - 7.4.5.5.2 Market size and forecast, by Application
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Product
  - 7.4.5.6.2 Market size and forecast, by Application
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
  - 7.5.2.1 LAMEA Embolic Agents Vascular Embolization Market by Type
  - 7.5.2.2 LAMEA Embolization Devices Vascular Embolization Market by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Product
  - 7.5.5.1.2 Market size and forecast, by Application
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Product
  - 7.5.5.2.2 Market size and forecast, by Application
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Product
  - 7.5.5.3.2 Market size and forecast, by Application
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Product
  - 7.5.5.4.2 Market size and forecast, by Application
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 BOSTON SCIENTIFIC CORPORATION
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 MERIT MEDICAL SYSTEMS
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 TERUMO CORPORATION
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 MEDTRONIC PLC
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 ABBOTT LABORATORIES
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 DEPUY SYNTHES (J&J MEDICAL DEVICES)
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 COOK MEDICAL
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 BALT
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 KANEKA CORPORATION
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 STRYKER CORPORATION
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments